Emcure Pharmaceuticals Ltd. Live Share Price Today, Share Analysis and Chart

Name: Emcure Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Emcure Pharmaceuticals Ltd.
Rating: 2.917208375
Author: Trendlyne DVM scores

Mid-range Performer

about

Incorporated in 1981, Emcure Pharmaceuticals is engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company's product portfolio includes orals, injectables a...

1370.70 -0.70 (-0.05%)

54.18% Gain from 52W Low

66,630

NSE+BSE Volume

NSE 04 Sep, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

High Financial Strength

70.0 / 100

Mid Valuation

41.7 / 100

Technically Neutral

51.7 / 100

Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM

1,653

1Yr Price target upside is 21%

4 analysts

Emcure Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Emcure Pharmaceuticals Ltd. Live Share Price Today, Share Analysis and Chart

Incorporated in 1981, Emcure Pharmaceuticals is engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company's product portfolio includes orals, injectables a...

54.18% Gain from 52W Low

SWOT Analysis

Emcure Pharma Live Price Chart